| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bacteria as a double-action sword in cancer
|
Yaghoubi, Atieh
|
|
|
1874 |
1 |
p.
|
artikel
|
| 2 |
Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients
|
Muniyan, Sakthivel
|
|
|
1874 |
1 |
p.
|
artikel
|
| 3 |
Cholesterol metabolism: New functions and therapeutic approaches in cancer
|
Xu, Huanji
|
|
|
1874 |
1 |
p.
|
artikel
|
| 4 |
Classification of extrachromosomal circular DNA with a focus on the role of extrachromosomal DNA (ecDNA) in tumor heterogeneity and progression
|
Liao, Zhenyu
|
|
|
1874 |
1 |
p.
|
artikel
|
| 5 |
CRISPR screen in mechanism and target discovery for cancer immunotherapy
|
Liu, Dan
|
|
|
1874 |
1 |
p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
1874 |
1 |
p.
|
artikel
|
| 7 |
Emerging functions and clinical prospects of connexins and pannexins in melanoma
|
Varela-Vázquez, Adrián
|
|
|
1874 |
1 |
p.
|
artikel
|
| 8 |
Emerging roles of HSF1 in cancer: Cellular and molecular episodes
|
Wang, Ge
|
|
|
1874 |
1 |
p.
|
artikel
|
| 9 |
Enzyme-based autophagy in anti-neoplastic management: From molecular mechanisms to clinical therapeutics
|
Ajoolabady, Amir
|
|
|
1874 |
1 |
p.
|
artikel
|
| 10 |
ETV6 gene aberrations in non-haematological malignancies: A review highlighting ETV6 associated fusion genes in solid tumors
|
Biswas, Angana
|
|
|
1874 |
1 |
p.
|
artikel
|
| 11 |
Extracellular vesicle-based liquid biopsy holds great promise for the management of ovarian cancer
|
Zheng, Xiaocui
|
|
|
1874 |
1 |
p.
|
artikel
|
| 12 |
FOX transcription factor family in hepatocellular carcinoma
|
Gong, Zhongqin
|
|
|
1874 |
1 |
p.
|
artikel
|
| 13 |
Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics
|
Hatami, Elham
|
|
|
1874 |
1 |
p.
|
artikel
|
| 14 |
Immunomodulatory effects of ablation therapy on tumors: Potentials for combination with immunotherapy
|
Qian, Ling
|
|
|
1874 |
1 |
p.
|
artikel
|
| 15 |
Killing the “BAD”: Challenges for immunotherapy in pancreatic cancer
|
Li, Tian-Jiao
|
|
|
1874 |
1 |
p.
|
artikel
|
| 16 |
Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy
|
Zhao, Yan
|
|
|
1874 |
1 |
p.
|
artikel
|
| 17 |
Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor’s arsenal
|
Mundry, Clara S.
|
|
|
1874 |
1 |
p.
|
artikel
|
| 18 |
Molecular subtyping in pancreatic neuroendocrine neoplasms: New insights into clinical, pathological unmet needs and challenges
|
Yan, Jie
|
|
|
1874 |
1 |
p.
|
artikel
|
| 19 |
New insights on sorafenib resistance in liver cancer with correlation of individualized therapy
|
Cheng, Zhang
|
|
|
1874 |
1 |
p.
|
artikel
|
| 20 |
Nucleic acid nanotechnology for cancer treatment
|
Jin, Jun-O
|
|
|
1874 |
1 |
p.
|
artikel
|
| 21 |
PERP-ing into diverse mechanisms of cancer pathogenesis: Regulation and role of the p53/p63 effector PERP
|
Roberts, Owain
|
|
|
1874 |
1 |
p.
|
artikel
|
| 22 |
Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types
|
van den Ende, Tom
|
|
|
1874 |
1 |
p.
|
artikel
|
| 23 |
Therapeutic aspects of AMPK in breast cancer: Progress, challenges, and future directions
|
Ponnusamy, Lavanya
|
|
|
1874 |
1 |
p.
|
artikel
|
Tijdschrift beschrijving